INSULET CORPORATION Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
INSULET CORPORATION (PODD) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $5.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-05
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $74.90M, a 11.29% increase year-over-year.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$69.30M.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-06-30 was $67.30M.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-03-31 was -$48.60M.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $133.90M, a 489.87% increase from fiscal 2021.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $22.70M, a 18.35% decline from fiscal 2020.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2020 was $27.80M, a 57.06% increase from fiscal 2019.
- INSULET CORPORATION increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2019 was $17.70M, a 31.66% decline from fiscal 2018.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $74.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.60M 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | -$69.30M 10-Q · filed 2026-05-06 | ||||||
| 2025-06-30 | $67.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $18.70M 10-Q · filed 2026-08-05 | |||||
| 2025-03-31 | -$48.60M 10-Q · filed 2026-05-06 | ||||||
| 2023-03-31 | -$35.90M 10-Q · filed 2023-05-05 | $10.20M derived: sum of 2 quarters · filed 2023-05-05 | $59.80M derived: sum of 3 quarters · filed 2023-05-05 | $131.70M derived: sum of 4 quarters · filed 2023-05-05 | |||
| 2022-12-31 | $46.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $95.70M derived: sum of 2 quarters · filed 2023-02-24 | $167.60M derived: sum of 3 quarters · filed 2023-02-24 | $133.90M 10-K · filed 2023-02-24 | |||
| 2022-09-30 | $49.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $121.50M derived: sum of 2 quarters · filed 2022-11-04 | $87.80M 10-Q · filed 2022-11-04 | $116.10M derived: sum of 4 quarters · filed 2023-05-05 | |||
| 2022-06-30 | $71.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $38.20M 10-Q · filed 2022-08-05 | $66.50M derived: sum of 3 quarters · filed 2023-05-05 | $66.20M derived: sum of 4 quarters · filed 2023-05-05 | |||
| 2022-03-31 | -$33.70M 10-Q · filed 2023-05-05 | -$5.40M derived: sum of 2 quarters · filed 2023-05-05 | -$5.70M derived: sum of 3 quarters · filed 2023-05-05 | $16.90M derived: sum of 4 quarters · filed 2023-05-05 | |||
| 2021-12-31 | $28.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $28.00M derived: sum of 2 quarters · filed 2023-02-24 | $50.60M derived: sum of 3 quarters · filed 2023-02-24 | $22.70M 10-K · filed 2023-02-24 | $24.40M 10-K · filed 2022-02-24 | ||
| 2021-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $22.30M derived: sum of 2 quarters · filed 2022-11-04 | -$5.60M 10-Q · filed 2022-11-04 | -$4.70M 10-Q · filed 2021-11-05 | $12.40M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | $22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$5.30M 10-Q · filed 2022-08-05 | $12.70M derived: sum of 3 quarters · filed 2023-02-24 | $29.00M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-03-31 | -$27.90M 10-Q · filed 2022-05-06 | -$28.00M 10-Q · filed 2021-05-07 | -$9.90M derived: sum of 2 quarters · filed 2023-02-24 | $6.40M derived: sum of 3 quarters · filed 2023-02-24 | $9.50M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2020-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $34.30M derived: sum of 2 quarters · filed 2023-02-24 | $37.40M derived: sum of 3 quarters · filed 2023-02-24 | $27.80M 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $19.40M derived: sum of 2 quarters · filed 2021-11-05 | $9.80M 10-Q · filed 2021-11-05 | ||||
| 2020-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$6.50M 10-Q · filed 2021-08-06 | |||||
| 2020-03-31 | -$9.60M 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | $17.70M 10-K · filed 2022-02-24 | ||||||
| 2018-12-31 | $25.90M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |